Animal models for human contiguous gene syndromes and other genomic disorders

Katherina Walz, Patricia Fonseca, James R. Lupski

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Genomic disorders refer to a group of syndromes caused by DNA rearrangements, such as deletions and duplications, which result in an alteration of normal gene dosage. The chromosomal rearrangements are usually relatively small and often difficult to detect cytogenetically. In a subset of such conditions the rearrangements comprise multiple unrelated contiguous genes that are physically linked and thus have been referred to as contiguous gene syndromes (CGS). In general, each syndrome presents a complex clinical phenotype that has been attributed generally to dosage sensitive gene(s) present in the responsible chromosomal interval. A common mechanism for CGS resulting from interstitial deletion/duplication has recently been elucidated. The DNA rearrangements result from nonallelic homologous recombination (NAHR) utilizing flanking low-copy repeats (LCRs) as recombination substrates. The resulting rearrangements often involve the same genomic region, a common deletion or duplication, making it difficult to assign a specific phenotype or enclophenotype to a single responsible gene. The human and mouse genome sequencing projects, in conjunction with the ability to engineer mouse chromosome rearrangements, have enabled the production of mouse models for CGS and genomic disorders. In this review we present an overview of different techniques utilized to generate mouse models for selected genomic disorders. These models foment novel insights into the specific genes that convey the phenotype by dosage and/or position effects and provide opportunities to explore therapeutic options. Copyright by The Brazilian Society Genetics.

Original languageEnglish
Pages (from-to)305-320
Number of pages16
JournalGenetics and Molecular Biology
Volume27
Issue number3
StatePublished - Dec 1 2004
Externally publishedYes

Fingerprint

Animal Models
Genes
Gene Dosage
Gene Rearrangement
Phenotype
Genomic Segmental Duplications
Homologous Recombination
Human Genome
Genetic Recombination
Chromosomes
Therapeutics

Keywords

  • Contiguous gene syndromes
  • Genomic disorders
  • Microdeletion
  • Microduplication

ASJC Scopus subject areas

  • Genetics

Cite this

Animal models for human contiguous gene syndromes and other genomic disorders. / Walz, Katherina; Fonseca, Patricia; Lupski, James R.

In: Genetics and Molecular Biology, Vol. 27, No. 3, 01.12.2004, p. 305-320.

Research output: Contribution to journalArticle

Walz, Katherina ; Fonseca, Patricia ; Lupski, James R. / Animal models for human contiguous gene syndromes and other genomic disorders. In: Genetics and Molecular Biology. 2004 ; Vol. 27, No. 3. pp. 305-320.
@article{12982a8c985b43509c0feefc878b9413,
title = "Animal models for human contiguous gene syndromes and other genomic disorders",
abstract = "Genomic disorders refer to a group of syndromes caused by DNA rearrangements, such as deletions and duplications, which result in an alteration of normal gene dosage. The chromosomal rearrangements are usually relatively small and often difficult to detect cytogenetically. In a subset of such conditions the rearrangements comprise multiple unrelated contiguous genes that are physically linked and thus have been referred to as contiguous gene syndromes (CGS). In general, each syndrome presents a complex clinical phenotype that has been attributed generally to dosage sensitive gene(s) present in the responsible chromosomal interval. A common mechanism for CGS resulting from interstitial deletion/duplication has recently been elucidated. The DNA rearrangements result from nonallelic homologous recombination (NAHR) utilizing flanking low-copy repeats (LCRs) as recombination substrates. The resulting rearrangements often involve the same genomic region, a common deletion or duplication, making it difficult to assign a specific phenotype or enclophenotype to a single responsible gene. The human and mouse genome sequencing projects, in conjunction with the ability to engineer mouse chromosome rearrangements, have enabled the production of mouse models for CGS and genomic disorders. In this review we present an overview of different techniques utilized to generate mouse models for selected genomic disorders. These models foment novel insights into the specific genes that convey the phenotype by dosage and/or position effects and provide opportunities to explore therapeutic options. Copyright by The Brazilian Society Genetics.",
keywords = "Contiguous gene syndromes, Genomic disorders, Microdeletion, Microduplication",
author = "Katherina Walz and Patricia Fonseca and Lupski, {James R.}",
year = "2004",
month = "12",
day = "1",
language = "English",
volume = "27",
pages = "305--320",
journal = "Genetics and Molecular Biology",
issn = "1415-4757",
publisher = "Brazilian Society of Genetics",
number = "3",

}

TY - JOUR

T1 - Animal models for human contiguous gene syndromes and other genomic disorders

AU - Walz, Katherina

AU - Fonseca, Patricia

AU - Lupski, James R.

PY - 2004/12/1

Y1 - 2004/12/1

N2 - Genomic disorders refer to a group of syndromes caused by DNA rearrangements, such as deletions and duplications, which result in an alteration of normal gene dosage. The chromosomal rearrangements are usually relatively small and often difficult to detect cytogenetically. In a subset of such conditions the rearrangements comprise multiple unrelated contiguous genes that are physically linked and thus have been referred to as contiguous gene syndromes (CGS). In general, each syndrome presents a complex clinical phenotype that has been attributed generally to dosage sensitive gene(s) present in the responsible chromosomal interval. A common mechanism for CGS resulting from interstitial deletion/duplication has recently been elucidated. The DNA rearrangements result from nonallelic homologous recombination (NAHR) utilizing flanking low-copy repeats (LCRs) as recombination substrates. The resulting rearrangements often involve the same genomic region, a common deletion or duplication, making it difficult to assign a specific phenotype or enclophenotype to a single responsible gene. The human and mouse genome sequencing projects, in conjunction with the ability to engineer mouse chromosome rearrangements, have enabled the production of mouse models for CGS and genomic disorders. In this review we present an overview of different techniques utilized to generate mouse models for selected genomic disorders. These models foment novel insights into the specific genes that convey the phenotype by dosage and/or position effects and provide opportunities to explore therapeutic options. Copyright by The Brazilian Society Genetics.

AB - Genomic disorders refer to a group of syndromes caused by DNA rearrangements, such as deletions and duplications, which result in an alteration of normal gene dosage. The chromosomal rearrangements are usually relatively small and often difficult to detect cytogenetically. In a subset of such conditions the rearrangements comprise multiple unrelated contiguous genes that are physically linked and thus have been referred to as contiguous gene syndromes (CGS). In general, each syndrome presents a complex clinical phenotype that has been attributed generally to dosage sensitive gene(s) present in the responsible chromosomal interval. A common mechanism for CGS resulting from interstitial deletion/duplication has recently been elucidated. The DNA rearrangements result from nonallelic homologous recombination (NAHR) utilizing flanking low-copy repeats (LCRs) as recombination substrates. The resulting rearrangements often involve the same genomic region, a common deletion or duplication, making it difficult to assign a specific phenotype or enclophenotype to a single responsible gene. The human and mouse genome sequencing projects, in conjunction with the ability to engineer mouse chromosome rearrangements, have enabled the production of mouse models for CGS and genomic disorders. In this review we present an overview of different techniques utilized to generate mouse models for selected genomic disorders. These models foment novel insights into the specific genes that convey the phenotype by dosage and/or position effects and provide opportunities to explore therapeutic options. Copyright by The Brazilian Society Genetics.

KW - Contiguous gene syndromes

KW - Genomic disorders

KW - Microdeletion

KW - Microduplication

UR - http://www.scopus.com/inward/record.url?scp=26844506863&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=26844506863&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:26844506863

VL - 27

SP - 305

EP - 320

JO - Genetics and Molecular Biology

JF - Genetics and Molecular Biology

SN - 1415-4757

IS - 3

ER -